Medications for Brain Neoplasms

9 results
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Usage: Carmustine for Injection, USP is indicated for palliative therapy as a single agent or in combination therapy for brain tumors (e.g., glioblastoma), multiple myeloma (with prednisone), and relapsed or refractory Hodgkin's and Non-Hodgkin's lymphomas (with other approved drugs).
Sandoz Inc.
Usage: Carmustine for injection is indicated for palliative therapy as a single agent or in combination for brain tumors, multiple myeloma (with prednisone), and relapsed or refractory Hodgkin's and Non-Hodgkin's lymphomas (with other approved drugs).
Accord Healthcare Inc.
Usage: Carmustine for Injection is indicated for palliative therapy in brain tumors (e.g., glioblastoma), multiple myeloma (with prednisone), and relapsed or refractory Hodgkin's and Non-Hodgkin's lymphomas (in combination with other approved drugs).
H.J. Harkins Company Inc
Usage: This drug is indicated for severe allergic conditions, dermatologic diseases, adrenal insufficiency, gastrointestinal diseases, hematologic disorders, neoplastic diseases, nervous system disorders, ophthalmic diseases, renal diseases, respiratory diseases, and rheumatic disorders, providing symptomatic relief and management in these conditions.
Prasco Laboratories
Usage: The drug is indicated for severe allergies, dermatologic and endocrine disorders, gastrointestinal and hematologic diseases, neurogenic conditions, neoplastic diseases, and various conditions across respiratory, ophthalmic, renal, and rheumatic diseases. It serves to manage symptoms or provide palliative care in specific cases.
Amneal Pharmaceuticals NY LLC
Usage: This drug is indicated for severe allergic conditions, dermatologic and endocrine disorders, gastrointestinal issues, hematologic disorders, certain cancers, acute nervous system conditions, ocular inflammation, renal diseases, respiratory conditions, and as adjunctive therapy for rheumatic disorders. It addresses various severe and chronic health issues unresponsive to standard treatments.
NuCare Pharmaceuticals,Inc.
Usage: This drug is indicated for severe allergic conditions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematologic disorders, neoplastic diseases, nervous system issues, ophthalmic diseases, renal diseases, respiratory diseases, and rheumatic disorders. It serves various roles including adjunctive therapy and management of acute episodes.
NextSource Biotechnology, LLC
Usage: Gleostine is indicated for treating primary and metastatic brain tumors post-surgery/radiotherapy and is used in combination chemotherapy for Hodgkin's lymphoma patients whose disease has advanced after initial treatment.
Quality Care Products, LLC
Usage: This drug is indicated for severe allergic conditions, dermatologic diseases, adrenocortical insufficiency, gastrointestinal issues, hematologic disorders, and various others including nervous system conditions, ophthalmic diseases, renal diseases, respiratory diseases, and rheumatic disorders, among others. It is used in both acute and chronic management.